{name}
{subtitle}
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
city
~17 mi. (Airdrie, United Kingdom, +141 more cities)
facility
GSK Investigational Site
drug type
chemotherapy, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~27 mi. (Glasgow, United Kingdom, +176 more cities)
facility
Beatson West of Scotland Cancer Centre ( Site 2247)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~27 mi. (Glasgow, United Kingdom, +199 more cities)
facility
The Beatson West of Scotland Cancer Centre ( Site 0750)
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~27 mi. (Glasgow, United Kingdom, +127 more cities)
facility
NHS Greater Glasgow and Clyde /ID# 215663
drug
azacitidine, +2 more drugs
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~27 mi. (Glasgow, United Kingdom, +156 more cities)
facility
NHS Greater Glasgow and Clyde /ID# 202199
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
city
~27 mi. (Glasgow, United Kingdom, +70 more cities)
facility
The Beatson West of Scotland Cancer Centre ( Site 0909)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type